MARKET WIREYahoo Finance • 1d ago
Merit Medical Systems (MMSI) Stock Looks Cheap Based On Cash FlowYahoo Finance report covering Merit Medical Systems Inc. (MMSI) market action, institutional positioning, and fundamental catalysts.
Why MMSI Stock dropped -2.24% Today — RQD Quant Desk Flash
$84.31 -2.24% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $83.81
Merit Medical Systems Inc. (MMSI) carries a Roarable Rating of C+ (Hold) with 68/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
ROARABLE C+ • HOLD / WATCH
Cap $5.17B
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on MMSI Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is MMSI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Merit Medical Systems Inc. (NASDAQ: MMSI) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 68/100 at a spot price of $84.31 (-2.24% 1D, market cap $5.17B). Pillar breakdown: Fundamental Cash Engine 15/20, Institutional 13F & Options Flow 11/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 12/20, and Executive Insider Alignment 12/20. Across 1015 tracked Health Care issuers, MMSI ranks #92 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does MMSI compare to MMED and HTFL in the Health Care sector?
▼
Within the Health Care sector (Medical/Dental Instruments), MMSI carries a Roarable C+ (68/100 RQD), trailing P/E of 43.4x, gross margin of 48.7%, and ROIC of 7.8%. By comparison, MMED (MiniMed Group Inc.) holds a D grade (44/100 RQD, P/E N/A, ROIC -3.9%, cap $5.14B) and HTFL (Heartflow Inc.) posts a D+ grade (53/100 RQD, P/E N/A, ROIC -12.0%, cap $5.13B). Among the 5-stock peer group, MMSI leads on earnings multiple (43.4x) while HAE leads on capital efficiency (8.4% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for MMSI?
▼
Per MMSI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000856982), Merit Medical Systems Inc. generated $1.52B in revenue (+11.8% YoY), $128.5M in net income, and $215.7M in free cash flow against $2.69B in total assets and $734.0M in total debt. Key quantitative strengths: Strong cash generator (48.7% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Priced at 43x earnings—high expectations leave less room for a lukewarm quarter. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $83.81 (-0.59%)🧬 Cannibal Buyback (-1.24% YoY Shares)⚙️ Cash Engine: 15/20 (B) • 14.2% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 68/100 (C+) historically posted market-perform odds over rolling 90-day windows (+1.8% avg 90D alpha vs SPY • 56.9% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERHOLD / WATCH • C+
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw C · Rk B
Each axis scored 0–20
12M PRICE TARGET CONE+4.5% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MMSI)Realized 20D OHLCV Swing Band: ±6.3%
Deterministic 5-Pillar Attribution (68/100 Composite)
🔍 WHY MMSI SCORES 68/100 (C+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (26% of score)
Altman Z-Score 4.62 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 9/9
▲ #2 Bullish Driver: Cash Engine Quality+15/20 pts (22% of score)
SEC XBRL FY 2025 (10-K): 14.2% FCF Margin ($215.7M FCF) & 48.7% Gross Margin
▼ #1 Drag / Risk Factor: Whale & Options Positioning11/20 pts (-9 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-9 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade B+$87.16+4.9% Next Q
76
Q2 (-2Q)Grade B$91.40+0.9% Next Q
73
Q3 (-1Q)Grade B$92.21-8.6% Next Q
71
CurrentGrade C+$84.31+1.8% Hist 90D α
68
Trajectory: B+ (76) → C+ (68)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the MMSI Bull Thesis Could Fail
Even with a 68/100 (C+) score, MMSI faces multiple-compression risk if 43.4x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Priced at 43x earnings—high expectations leave less room for a lukewarm quarter.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Cannibal Buyback (-1.24% YoY Shares) — any gross margin slip below 46.2% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($88.62) or 200D SMA ($77.09) invalidates the momentum regime and cuts Target Base ($88.10) toward Bear Floor ($68.72).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $MMSI• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “MMSI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why MMSI Stock dropped -2.24% Today — RQD Quant Desk Flash
Merit Medical Systems Inc. (MMSI) dropped -2.24% to $84.31, trading at 70% of its 52-week range ($59.74 – $94.85). Solid 48.7% gross margin (8% return on capital), mixed timing at 43x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 70% of its 52-week range ($59.74 – $94.85) with RSI-14 at 43.5 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±6.3% around $84.31 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C+ (Hold) backed by 48.7% gross margin and $215.7M annual free cash flow.
Live MMSI Headlines & Catalysts
CATALYSTSeeking Alpha • 1d ago
Merit Medical Systems: A Solid Q3, While Adding New Growth EnginesSeeking Alpha report covering Merit Medical Systems Inc. (MMSI) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance • 1d ago
Merit Medical Systems (MMSI) Stock Could Be Slightly Undervalued On Cash FlowYahoo Finance report covering Merit Medical Systems Inc. (MMSI) market action, institutional positioning, and fundamental catalysts.
CATALYSTTradingView • 1d ago
Merit Medical Systems, Inc. Stock 12‑Month Price Target Raised to $106.5, Implies 14% UpsideTradingView report covering Merit Medical Systems Inc. (MMSI) market action, institutional positioning, and fundamental catalysts.
CATALYSTGuruFocus • 1d ago
Merit Medical Systems (MMSI) Reports Solid Q3 Revenue Growth and Updates 2026 GuidanceGuruFocus report covering Merit Medical Systems Inc. (MMSI) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance • 1d ago
Merit Medical Systems (MMSI) Rallies On Margin Progress, Is The Stock Still Cheap?Yahoo Finance report covering Merit Medical Systems Inc. (MMSI) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingView • 1d ago
Medical Devices & Supplies - Cardiology, Neurology, Vascular Q2 Earnings: Merit Medical Systems (NASDAQ:MMSI) Simply the BestTradingView report covering Merit Medical Systems Inc. (MMSI) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance • 1d ago
Here's Why You Should Add Merit Medical Stock to Your Portfolio NowYahoo Finance report covering Merit Medical Systems Inc. (MMSI) market action, institutional positioning, and fundamental catalysts.
CATALYSTYahoo • 2d ago
MMSI Q3 deep dive: balanced organic growth, new acquisitions, and margin improvementMedical device company Merit Medical Systems (NASDAQ:MMSI) beat Wall Street’s revenue expectations in Q3 2026, with sales up 8.4% year on year to $416.2 million. The company expects the full year’s revenue to be around $
CATALYSTYahoo • 3d ago
Merit Medical Shares In Focus After Earnings Beat And Higher 2026 GuidanceMerit Medical Systems reported Q3 2026 revenue of US$416.24 million and net income of US$42.31 million, with management lifting full year guidance and highlighting broad based demand across its product platforms. An impo
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk
Scheduled RQD Strong Buys & Whale Accumulation Briefing (MMSI Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
MMSI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +35.96%▼ SUPPORT BREAKDOWN
2026-11-03O $93.39H $93.39L $84.31C $84.31VOL 1.80M
RES: $95.21SUP: $84.69SMA50: $88.62SMA200: $77.09
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
MMSI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle
32.6%/yr Implied 5Y Growth
vs. +11.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger
No active Ellis Vennor swing setup published on MMSI today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for MMSI. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for MMSI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MMSI)
Health Care Rank #92 of 1015
⚔️ MMED vs MMSI Full Matrix →
1. Head-to-Head Health Care Peer Comparison (MMSI vs. MMED, HTFL, STVN, HAE)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1015 tracked Health Care securities in the Roarable RQD universe, Merit Medical Systems Inc. (MMSI) ranks #92 by composite RQD confidence (68/100, grade C+) and #157 by equity capitalization ($5.17B). Within this direct 5-issuer industry benchmark cohort, MMSI leads on earnings valuation at 43.4x trailing P/E, while HAE leads on capital efficiency and profitability with 8.4% ROIC and 59.0% gross margin. HAE currently holds the highest overall quantitative score in the immediate peer group at 74/100 (B) compared with MMSI at 68/100 (C+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| MMSI
ACTIVE
Merit Medical Systems Inc. | C+ | 68/100 | 43.4x | 48.7% | 7.8% | -2.24% | $5.17B | Benchmark Subject |
| MMED MiniMed Group Inc. | D | 44/100 | — | 54.2% | -3.9% | +3.39% | $5.14B | /mmed-vs-mmsi → |
| HTFL Heartflow Inc. | D+ | 53/100 | — | 76.8% | -12.0% | -7.72% | $5.13B | /htfl-vs-mmsi → |
| STVN Stevanato Group S.p.A. | D+ | 54/100 | — | — | — | +1.86% | $5.29B | /stvn-vs-mmsi → |
| HAE Haemonetics Corporation | B | 74/100 | — | 59.0% | 8.4% | +0.41% | $5.44B | /hae-vs-mmsi → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000856982 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), Merit Medical Systems Inc. (MMSI) reported GAAP revenue of $1.52B (+11.8% vs. FY2024 revenue of $1.36B , and +20.6% cumulative change since FY2023) , GAAP net income of $128.5M, operating cash flow of $297.4M, and free cash flow of $215.7M (+16.2% YoY). On the balance sheet, MMSI closed FY2025 with $2.69B in total assets against $734.0M in total debt (Altman Z-Score: 4.62, Piotroski F-Score: 9/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $1.52B | $128.5M | $297.4M | $215.7M | $2.69B | $734.0M |
| FY2024 (FY) | 2024-12-31 | $1.36B | $120.4M | $220.8M | $185.7M | $2.42B | $729.6M |
| FY2023 (FY) | 2023-12-31 | $1.26B | $94.4M | $145.2M | $88.6M | $3.07B | $717.7M |
3. MMSI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs MMSI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Merit Medical Systems Inc. (NASDAQ: MMSI) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 68/100 at a spot price of $84.31 (-2.24% 1D, market cap $5.17B). Pillar breakdown: Fundamental Cash Engine 15/20, Institutional 13F & Options Flow 11/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 12/20, and Executive Insider Alignment 12/20. Across 1015 tracked Health Care issuers, MMSI ranks #92 in composite RQD confidence.
How does MMSI compare to MMED and HTFL in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), MMSI carries a Roarable C+ (68/100 RQD), trailing P/E of 43.4x, gross margin of 48.7%, and ROIC of 7.8%. By comparison, MMED (MiniMed Group Inc.) holds a D grade (44/100 RQD, P/E N/A, ROIC -3.9%, cap $5.14B) and HTFL (Heartflow Inc.) posts a D+ grade (53/100 RQD, P/E N/A, ROIC -12.0%, cap $5.13B). Among the 5-stock peer group, MMSI leads on earnings multiple (43.4x) while HAE leads on capital efficiency (8.4% ROIC).
What are the biggest fundamental strengths and SEC risk factors for MMSI?
Per MMSI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000856982), Merit Medical Systems Inc. generated $1.52B in revenue (+11.8% YoY), $128.5M in net income, and $215.7M in free cash flow against $2.69B in total assets and $734.0M in total debt. Key quantitative strengths: Strong cash generator (48.7% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Priced at 43x earnings—high expectations leave less room for a lukewarm quarter. Institutional options positioning shows a 50% call / 50% put premium split.
Where is MMSI trading relative to its 50-day, 200-day, and 52-week technical levels?
MMSI last traded at $84.31 (-2.24% on volume of 1,203,845 shares), positioning the stock -4.86% below its 50-day simple moving average ($88.62) and +9.37% above its 200-day simple moving average ($77.09). Across its 52-week range of $59.74 to $94.85, MMSI sits at the 70.0% percentile with a 14-day RSI of 43.5 (NEUTRAL RANGE) and an implied next-earnings move of ±6.3% ($79.00 to $89.62).
ROARABLE RATING BRIEF • RQD 68/100 (C+)
✓ SEC XBRL & RQD VERIFIED
MMSI — Merit Medical Systems Inc.: What the Facts Mean to a Prospective Investor
Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31
1. Roarable Rating Brief: What This Means to a Prospective Investor
Merit Medical Systems Inc. (MMSI) earns a live Roarable RQD composite score of 68/100, corresponding to a C+ letter grade (Roarable Hold) at a spot price of $84.31 (-2.24% 1D, market capitalization $5.17B).
- Fundamental Cash Engine (15/20): Anchored by return on invested capital (ROIC) of 7.8%, gross margin of 48.7%, operating margin of 12.2%, and free cash flow yield of 3.87%.
- Whale 13F & Options Flow (11/20) + Insider Conviction (12/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (12/20) + Forensic Balance Sheet (18/20): Incorporates a 0.94x equity beta, Altman Z-Score of 4.62, Piotroski F-Score of 9/9, and Debt/Equity of 0.46x.
2. Business Model, Unit Margins & SEC Financial Trajectory
Merit Medical Systems Inc. Is a NASDAQ-listed issuer in the Health Care sector, Medical/Dental Instruments industry. Specific product lines, customer segments, and revenue-generation mechanics are — The profile section confirms only sector, industry, exchange, and market capitalization of $5.6B.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Merit Medical Systems Inc. (MMSI) reported $1.52B in annual revenue (up from $1.36B in FY2024, +11.8% YoY) and $128.5M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($1.26B revenue, $94.4M net income) through FY2025, MMSI scaled operating cash flow to $297.4M and free cash flow to $215.7M, backed by $2.69B in total assets against $734.0M in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (C+ • RQD 68/100): Strong cash generator (48.7% gross margin)—profits are backed by real money, not accounting tricks. Clean SEC annual filing review with no major hidden accounting time-bombs. With Fundamental Cash Engine at 15/20 and Institutional Whale Flow at 11/20, sustained execution supports upside toward the upper end of the $59.74 – $94.85 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Priced at 43x earnings—high expectations leave less room for a lukewarm quarter. Investors must weigh 43.4x trailing P/E and 23.1x EV/EBITDA against 12.2% operating margins and a 0.94x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Upstream and downstream dependencies, sector correlations, and second-order bottlenecks cannot be assessed from the provided sources.
- Key Question #1: Can MMSI sustain or expand its 12.2% operating margin and 7.8% ROIC against Medical/Dental Instruments peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $1.52B and free cash flow of $215.7M, how will capital allocation balance growth reinvestment against $734.0M in total debt?
- Key Question #3: How sensitive is MMSI's 40.4x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 0.94x)?
MMSI Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Merit Medical Systems Inc. (MMSI) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo Finance • 1d ago
Merit Medical Systems (MMSI) Stock Looks Cheap Based On Cash Flow Yahoo Finance report covering Merit Medical Systems Inc. (MMSI) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST Seeking Alpha • 1d ago
Merit Medical Systems: A Solid Q3, While Adding New Growth Engines Seeking Alpha report covering Merit Medical Systems Inc. (MMSI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance • 1d ago
Merit Medical Systems (MMSI) Stock Could Be Slightly Undervalued On Cash Flow Yahoo Finance report covering Merit Medical Systems Inc. (MMSI) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST TradingView • 1d ago
Merit Medical Systems, Inc. Stock 12‑Month Price Target Raised to $106.5, Implies 14% Upside TradingView report covering Merit Medical Systems Inc. (MMSI) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST GuruFocus • 1d ago
Merit Medical Systems (MMSI) Reports Solid Q3 Revenue Growth and Updates 2026 Guidance GuruFocus report covering Merit Medical Systems Inc. (MMSI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance • 1d ago
Merit Medical Systems (MMSI) Rallies On Margin Progress, Is The Stock Still Cheap? Yahoo Finance report covering Merit Medical Systems Inc. (MMSI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 1d ago
Medical Devices & Supplies - Cardiology, Neurology, Vascular Q2 Earnings: Merit Medical Systems (NASDAQ:MMSI) Simply the Best TradingView report covering Merit Medical Systems Inc. (MMSI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance • 1d ago
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now Yahoo Finance report covering Merit Medical Systems Inc. (MMSI) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
MMSI Bull vs. Bear Conversation Board — What's Your Call at $84.31?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON MMSI 🐻 33% BEARISH CONVICTION
BR BreakoutHunter RQD DEBATE OPENER • Swing & Catalyst Trader 🐂 BULLISH
🎯 Target: $103.49 (+20.0%)
📌 Pinned Debate Per the Roarable RQD rating, the Forensic Balance Sheet pillar scores 18/20 on Altman Z 4.62, Piotroski F 9/9, and Debt/Equity 0.46.
Long MMSI at $86.24 targeting $103.49. Per the Roarable RQD rating, the Forensic Balance Sheet pillar scores 18/20 on Altman Z 4.62, Piotroski F 9/9, and Debt/Equity 0.46.. Institutional whale score is 11/20 and the risk/reward vs. the $59.74 52-week low is skewed heavily in favor of bulls.
EarningsSniper 🐂 BULL
Both sides have a point here — MMSI's 18/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.
MU MultipleCompression RQD DEBATE OPENER • Valuation Discipline 🐻 BEARISH
🎯 Target: $67.27 (-22.0%)
Spot @ $86.24 At a P/E (TTM) of 43.4 and ROIC of 7.8%, the stock prices in substantial future earnings growth relative to its current returns.
I respect the product at Merit Medical Systems Inc., but the stock at $86.24 is a different story. At a P/E (TTM) of 43.4 and ROIC of 7.8%, the stock prices in substantial future earnings growth relative to its current returns.. FCF yield is 3.87% and RQD sits at 68/100 (C+) — why pay up here when you can wait for next quarter's numbers?